(EN)
The present invention discloses compounds which, are novel receptor antagonists for NPY Y5 as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such NPY Y5 receptor antagonists as well as methods of using them to treat obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes.
(ZH) 本发明公开了新的为NPY Y5受体拮抗剂的化合物和制备这些化合物的方法。在另一实施方案中,本发明公开了包含这样的NPY Y5受体拮抗剂的药用组合物以及用这些药用组合物治疗肥胖症、代谢紊乱、饮食障碍如高血脂和糖尿病的方法。